Wake Forest School of Medicine Translational Imaging Program Wake Forest Translational Science Institute (TSI) Akiva Mintz, MD, PhD, MHA.

Slides:

Advertisements

Similar presentations

Texas College of Osteopathic Medicine Building a Research Culture Upon a Foundation of Scholarly Success Marc B. Hahn, DO University of North Texas Health.

Advertisements

Phase 0 Imaging Studies From Regulations to Reality: Obtaining and Holding an IND at Your Institution Karen A. Kurdziel, MD Virginia Commonwealth University,

Department of Medicine Task Force on Research. Committee Charge  Develop a unifying vision to become leaders in translational research Achieve top 10.

Retreat Topics iPSC Opportunities in NIAMS Diseases Science Management Forum: Leveraging and Strategic Funding Collaborations Atopic Dermatitis Advancing.

SINAPSE Health Technology Innovation Prof David Wyper SINAPSE Director.

Stephen Klasko, MD, MBA Senior Vice President for USF Health Dean, College of Medicine 19 August 2010.

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Anantha Shekhar MD, PhD Indiana University School of Medicine Indiana Clinical and.

Research Protocol ACRIN 6678 Learning About PET/CT Scans: Can PET/CT scans provide helpful information for the treatment of non-small cell lung cancer?

UNC – NCRC January 2008 NC State Campus Steven Leath The University of North Carolina General Administration.

Harvard Catalyst Imaging Consortium Education Program.

Helena Chui, M.D. McCarron Professor and Chair of Neurology Director, Alzheimer Disease Research Center.

Medical College of Wisconsin Functional Imaging Research Center Stephen M. Rao, Ph.D., Director Professor of Neurology

Brian C. Springer, MHA Executive Director Siteman Cancer Center Barnes-Jewish Hospital & Washington U. School of Med CCSG-CTSA Interactions Michael Bertram,

Charge: Your task is to develop core ideas/projects for an $8-10M ($ M per year for 5 years) NIH Center proposal. Specifically, you should consider.

Centre for Health & Technology Maritta Perälä-Heape, PhD Director, CHT.

Harvard Catalyst: How Can It Help Your Research? Steven D. Freedman MD PhD Professor of Medicine, HMS Associate Dean for Clinical and Translational Research,

Clinical and Translational Science Award (CTSA) John F. Ennever Medical Director, CTO Director, RKSR.

1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical development Phase I Phase II Phase III Product.

1 Presentation title - edit in the Master slide 1 Current Investment Opportunities Professor Rory Shaw, Medical Director, Healthcare UK, UKTI.

Overview of the Harvard Catalyst Imaging program Randy Gollub,MD,PhD; Valerie Humblet,PhD April 28, 2009.

Improving Animal and Human Health by Accelerating Veterinary Centered Entrepreneurship.

AMERICAN COLLEGE OF RADIOLOGY March 23, OUR MISSION To foster the ongoing development of widely acceptable consistent imaging.

ZW GMP Lab for production of PET tracers for clinical and translational research Luc Mortelmans, Guy Bormans, Koen Van Laere, Christophe Deroose,

Biomarker - Advanced Technologies & Global Markets (2009 to 2014) Markets & Markets – Analyst Briefing Research Analyst : Kandarp Saraswat Moderator: Manisha.

Aberdeen Confidence in Concept Fund Prof Phil Hannaford Vice Principal – Research & Knowledge Exchange.

Recognition Of Team Science Faculty Appointments, Promotions and Titles at The Geisel School of Medicine at Dartmouth “Recognition by peers as an investigator.

Global Molecular Imaging Market: Industry Analysis, Trend and Growth, by Future Market Insights

Alzheimer’s disease Platforms for translational research.

Center for Excellence in Research “Managing a Scientific Laboratory” Navigating the University M. Elizabeth Fini, PhD Director, USC Institute for Genetic.

Imaging Core Laboratory Fall Meeting, 2011 Imaging Challenges for ACRIN sites Compliance and set-up Anthony M. Levering Assistant Director, Core lab.

Overview of the Harvard Catalyst Imaging program Randy Gollub,MD,PhD; Ron Kikinis, MD; Bruce Rosen, MD, PhD;Clare Tempany, MD; Valerie Humblet, PhD

SUPPORTING R&D IN LIFE SCIENCES DIAA ABDELRAHMAN /10/2014.

Development of Harvard Catalyst Imaging Consultation Service Simon K. Warfield, Ph.D. Valerie Humblet, Ph.D. on behalf of the CTSC Imaging Committee

Metals in Medicine Consortium Sydney Cancer Centre.

Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.

6/4/20161 Commitment & Efforts Toward Translational Science Subtitle Placeholder.

1 2-Topic Imaging Workshop: (1)Standards for Imaging Endpoints in Clinical Trials (2) Manufacturing of PET Radiopharmaceutical Products Wendy R. Sanhai,

Nuclear Medicine division status Jean-Michel Poutissou 7 th April 2011.

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH CTSI Funding Opportunities

National Center for Research Resources G. Iris Obrams, M.D., M.P.H., Ph.D. NCRR Update 5 August 2006.

Pathology Visions Conference Giri Iyer General Manager, Strategic Development Integrated IT Solutions 10/22/2007 Digital Pathology HCIT Visions – A GE.

Team Building: Critical Role of Interdisciplinary Research Teams in Translational Research C. Kent Osborne, M.D. Director, Lester and Sue Smith Breast.

Initiating phase 1 clinical trials in pediatric oncology National Cancer Institute Perspective Barry Anderson, MD, PhD Pediatric Section Cancer Therapy.

Overview of the Harvard Catalyst Imaging program ClareTempany, MD; Ron Kikinis, MD; Valerie Humblet, PhD April 9, 2009.

College of Medicine Resources in Support of Your Research Space, Money, Cores etc.

Development of Harvard Catalyst Imaging Consultation Service C.Tempany, MD; R.Kikinis, MD; R.Gollub,MD,PhD; V. Humblet, PhD

1 Imaging Community Critical Need #1: Standardized and Harmonized Multisite Imaging George Q. Mills, MD, MBA Vice President, Medical & Regulatory Relations.

NIH and the Clinical Research Enterprise Third Annual Medical Research Summit March 6, 2003 Mary S. McCabe National Institute of Health.

Harvard Catalyst Imaging Consortium Services Randy Gollub,MD,PhD Valerie Humblet, PhD April 6, 2009.

BERAC April 2004 Radiopharmaceutical Sub- committee Report.

NCI Division of Cancer Prevention Ongoing Activities at Frederick Facilities Presented By: Lori Minasian, M.D. Robert Shoemaker, Ph.D. October 1, 2015.

GE Healthcare FCC-FDA meeting: Enabling the Convergence of Communications and Medical Systems Tim Kottak, Executive, Design Controls July 26, 2010.

Wellcome Trust / Glaxo Smith Kline Translational Medicine Training Programme at Imperial College Dr Waljit Dhillo.

1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.

From the Valley of Death to the Bridge of Life: Models for De-Risking Early Translational Projects from Around the World.

Laura Baker, PhD Internal Medicine, Neurology, & Public Health Sciences Wake Forest School of Medicine Winston-Salem, NC USA.

Prof. Pavle R. Andjus, PhD Center for laser microscopy; Institute for physiology and biochemistry Faculty of Biology University of Belgrade, Belgrade SERBIA.

New Approaches to Metabolomics Research

Development of Harvard Catalyst Imaging Consultation Service

Learning About PET/CT Scans:

From Bench to Clinical Applications: Money Talks

Trial Innovation Network A new national collaborative initiative within the CTSA Program and is composed of three key organizational partners – the CTSA.

What is CICATS? The University of Connecticut, in partnership with regional hospitals, state agencies, and community health care organizations, has.

Clinical and Translational Science Awards Program

Trial Funding and Engagement: The NIH Sponsored CTSA Program

Retreat Topics iPSC Opportunities in NIAMS Diseases

European Prevention Alzheimer’s Dementia

Promoting and Accelerating New Evolving Nuclear Nano-Molecular PET/SPECT Imaging Technologies and Related Cyclotron Technologies in the Region Sang.

Center for Clinical and Translational Science

Presentation transcript:

Wake Forest School of Medicine Translational Imaging Program Wake Forest Translational Science Institute (TSI) Akiva Mintz, MD, PhD, MHA

Golden B. Transforming healthcare Organizations. Healthcare Quarterly; 10:2006 Change Success vs. Failure Translational Imaging Program

Imaging as a Value-Adding Proposition TQM13 Vision Resources Action Plan Discussion Newcastle upon Tyne

Clinical Scanners microPET Research PET Scanner Staff 7T Preclinical MRI Cyclotron Clinical Radiologists Radio- chemistry 3T Large Research MRI Regulatory Support Resources & Structure

Clinical Scanners microPET Research PET Scanner Staff 7T Preclinical MRI Cyclotron Clinical Radiologists Radio- chemistry 3T Large Research MRI Regulatory Support Resources & Structure

Clinical Scanners microPET Research PET Scanner Staff 7T Preclinical MRI Cyclotron Clinical Radiologists Radio- chemistry 3T Large Research MRI Regulatory Support Resources & Structure

Clinical Scanners microPET Research PET Scanner Staff 7T Preclinical MRI Cyclotron Clinical Radiologists Radio- chemistry 3T Large Research MRI Regulatory Support Resources & Structure

Translational Imaging Program Synergizing Assets

Preclinical and Clinical Synergy TQM13 Translational Imaging Program (TIP) Benchtop Bedside Research & Clinical Practice Preclinical Imaging Radio-Tracer Development

Translational Imaging Program Roadmap to Excellence Workflow Efficiency Collaboration Customer Satisfaction Education Innovation

Phys. Pharm Cardio. Diabetes Neuro BioEng. Aging Center Dementia Cancer Center WFIRM Synergizing Assets TIP Translational Imaging Program

Synergizing Assets Wake Innovation Industry Translational Imaging Program

7T Small Animal MRI Scanner microPET/CT Scanner Human Research PET/CT Scanner Radiotracer Synthesis Laboratory Cyclotron 3T MRI Translational Imaging Shared Resource Consultation – Multi modality expertise Access/Rates – negotiate center subsidized rates, PPG imaging cores Tracers – develop tracers in areas of institutional priority Proactive Catalyst – Work with potential investigators who do not currently use imaging Pilot mechanism Cross-pollinate novel imaging applications between seemingly unrelated projects – example: cancer metabolism and AD Value Added Translational Imaging Program

Proposed Structure Translational Imaging Program

Proposed Structure Translational Imaging Program TSI Team Chris OByrne Laurie Molloy Janeria McCullough Mike Kennedy Pattie Smith Rachel Woodside Lindsay Trost Meredith Hankins

Imaging as a Value-Adding Proposition TQM13 Vision Resources Action Plan Discussion Newcastle upon Tyne

TQM13 Technology/Equipment o Siemens 3.0T Large MRI o GE 16-slice PET/CT o Toshiba 32-slice CT o Imaging Informatics Infrastructure

TQM13 Technology/Equipment o Siemens 3.0T Large MRI o Bruker 7T small animal MRI o GE 16-slice PET/CT o Trifoil MicroPET/CT o Toshiba 32-slice CT o Imaging Informatics Infrastructure

TQM13 Tracer Manufacturing PET cGMP Production

Wake Forest Cyclotron (GE PET Trace) Wake Forest Radiotracer Synthesis Laboratory Trasis All-In-One GE TRACERlab FxC 4 Active Hot Cells TQM13 Tracer Manufacturing PET Tracer cGMP Production GE TRACERLAB FX MEI GE TRACERLAB FX M

TQM13 Agilent Gas Chromatography (GC) 3 HPLCs for QC and Development Terra Universal USP797- Compliant Class 5 Isolation Chamber TQM13 Tracer Manufacturing PET Tracer cGMP Production

Imaging as a Value-Adding Proposition TQM13 Vision Resources Action Plan Discussion Newcastle upon Tyne

Golden B. Transforming healthcare Organizations. Healthcare Quarterly; 10:2006 Change Success vs. Failure Translational Imaging Program

Administration Changes Translational Imaging Program Announcements New Website Electronic intake Updated contacts Outreach Pilot Program ID Areas of Need: Novel radiochemistry, Image Processing

TQM13 Key Areas Adaptive Clinical Trials/Early Response Metabolism Imaging Immune Modulation Clinical Protocol Development Imaging Pilots Immune Activation FA Metabolism Anti-mitochondrial Metabolism GBM Imaging Targeted Strategic Plans Example: Cancer

Novel Radiochemistry Small Animals Large Animals Clinical Trials Oncology Regenerative Med. AD/Neuroscience Metabolism Cardiology Partial Listing of Available Tracers 18 F-FLT 18 F-FMISO 11 C-Choline 11 C-Methionine 11 C-Acetate 11 C-PBR28 18 F-FMT 18 F-FES 18 F-FDHT 18 F-FDopa 89 Zr-mAb TQM13 Targeted Strategic Plans Example: Cancer

TQM13 TIP Alzheimer’s Disease Addiction Metabolism Diet Non Human Primate Models Cancer Bridging Foci to Create New Science Translational Imaging Program

Current Vision or Dream?